Get this delivered to your inbox, and more info about our products and services.
An under-the-radar medical device stock with 20% upside, according to the charts
Jay Woods breaks down the charts in Steris.
14 words~1 min read
Related reading
Breaking down the charts on this outperforming medical device maker
Chart analyst Frank Cappelleri goes through the charts that make this stock an attractive play.
Bank of America sees near-40% upside in this medtech stock
BofA analysts are bullish on this German medtech name ahead of its full-year earnings report.
It's a high-risk trade, but this biotech down 80% this year could be a buy
Jay Woods breaks down the charts on Sarepta.
This biotech firm has room to run despite surging nearly 500% in past year,…
The investment bank upgraded the pharma stock to overweight from equal weight.
This power stock has 30% upside thanks to future data center deals, Jefferies…
This power stock's shares have pulled back 25% since September, providing an attractive entry point, according to Jefferies.
This software stock has been on a wild ride. Where it's going next, according…
Jay Woods of Freedom Capital Markets breaks down the technicals on this software name.